It is rare for an exchange to sue the agency that supervises it. It is rarer still when that exchange is CME Group, home of ES, NQ and the Micros most retail futures traders use every day. But on June 18, 2026, CME filed suit in federal court in Washington, D.C., against the Commodity Futures Trading Commission and its chairman, Michael Selig, over the approval of perpetual futures.
How it unfolded
May 29: the CFTC approved KalshiEX's bitcoin perpetual (BTCPERP) and issued a related no-action position for Coinbase, alongside a policy statement on perpetual contracts.
June 17: CEO Terry Duffy told CNBC's "Fast Money" that CME would sue. CNBC's video headline carried his words: "I'm always up for a good battle" and "I won't shy away from this." According to Finance Magnates, Duffy said he had been working on the plan with his board for eight months. The same day, CME announced Duffy will step down as CEO and become executive chairman on March 1, 2027, with President and CFO Lynne Fitzpatrick becoming CEO.
June 18: CME filed Chicago Mercantile Exchange Inc. v. Selig, case 1:26-cv-02157 (D.D.C.), assigned to District Judge Colleen Kollar-Kotelly.
CME's argument
According to Dechert and Lowenstein Sandler summaries of the complaint, CME alleges:
- Perpetual contracts, which never expire and involve recurring funding payments between counterparties, meet the statutory definition of swaps under the Commodity Exchange Act as amended by Dodd-Frank, not futures.
- The CFTC reversed its longstanding position without adequate explanation.
- The agency adopted the new policy without notice-and-comment rulemaking, in violation of the Administrative Procedure Act.
CME is seeking to have the order vacated. Finance Magnates reported that CME also warned high-leverage perps with auto-liquidation mechanisms could risk a systemic crisis echoing 2008.
The CFTC's response
A CFTC spokesperson called the suit "frivolous," per Finance Magnates. On September 2, 2026, the agency moved to dismiss. CoinDesk and Crowdfund Insider reported the CFTC argues CME has not shown a legally cognizable injury, in other words, that losing potential business to a competitor is not grounds to sue. Crowdfund Insider reported the agency described the case as "much ado about nothing." CME's opposition was reported as due October 2.
Why futures traders should care
- Competition for your order flow. After the approval, Coinbase launched perpetual-style equity index futures, including an S&P 500 product, and in September filed for single-stock perps. If CME wins, that product line could be forced into the swaps regime, which is far less accessible to retail.
- Regulatory precedent. The case tests whether the CFTC can reshape product definitions by order and policy statement rather than formal rulemaking.
- Leadership transition. The fight will outlast Duffy's tenure as CEO. Fitzpatrick inherits it.
Both sides, honestly
CME's legal argument is not frivolous on its face: perps really do involve periodic exchanges of payments, which is how swaps are typically described. Its risk warning also has some grounding in how offshore perp venues have behaved in crashes. But CME is also the incumbent with the most to lose, and exchange stocks, including CME's, fell after the approval. The CFTC's standing argument essentially says: this is a business complaint dressed as a legal one.
Our take
Opinion: Both things can be true. CME is protecting its moat, and CME is raising a real legal question the CFTC chose to answer without a full rulemaking. For traders, the best outcome is a clear rule either way. The worst outcome is years of uncertainty where new perp products launch, gather retail money, and then face being reclassified. If you trade anything perp-shaped on a US venue, keep an eye on this docket.
What traders can do
- Treat regulated US perps as legally unsettled until the court rules.
- Don't move a core strategy to a product whose legal status could change mid-trade without a plan B.
- Watch for the court's ruling on the motion to dismiss, the next major milestone.
Key takeaways
- CME sued the CFTC and Chairman Selig on June 18, 2026 in D.C. federal court.
- CME argues perps are swaps under Dodd-Frank and that the CFTC skipped rulemaking.
- The CFTC moved to dismiss on September 2, arguing CME lacks a cognizable injury.
- Duffy hands the CEO role to Lynne Fitzpatrick on March 1, 2027.
Put the research to work on your Desk
Explore the tools behind the research, compare the available access, or open your Desk if you already have an account.
FAQ
Why did CME sue the CFTC?
CME alleges the CFTC's May 29, 2026 approval of Kalshi's bitcoin perpetual unlawfully treated perpetual contracts as futures rather than swaps, reversed prior positions without explanation, and skipped notice-and-comment rulemaking.
What did the CFTC say?
A CFTC spokesperson called the suit frivolous, and on September 2, 2026 the agency moved to dismiss, arguing CME has not shown a legally cognizable injury.
Is Terry Duffy leaving CME?
CME announced on June 17, 2026 that Duffy will step down as CEO and become executive chairman on March 1, 2027, with Lynne Fitzpatrick becoming CEO.
Loomi.Ai provides educational market research, not financial advice. Trading futures and options involves substantial risk of loss, and backtested results are historical and do not guarantee future returns.
Sources
- CME CEO Terrence Duffy says the exchange operator will sue CFTC over perpetual futures, CNBC
- CME Sues CFTC Over Approval of Cryptocurrency Perpetual Futures Contracts, Bloomberg
- Perpetual Contracts Update: CME Takes CFTC to Court, Dechert
- Chicago Mercantile Exchange Inc. v. Selig 1:26-cv-02157 (D.D.C.), Civil Rights Litigation Clearinghouse
- "Always Up for a Good Battle": CME Takes Aim at CFTC in High-Stakes Lawsuit Over Perps, Finance Magnates
- CFTC asks judge to dismiss CME lawsuit over crypto perpetual futures, CoinDesk
- CFTC Asks Court To Dismiss CME Group Lawsuit Over Crypto Perpetual Futures, Crowdfund Insider
- CME Group's Terry Duffy to step down in 2027, CFO Lynne Fitzpatrick to become CEO, CNBC